Insud (Innovation, Sustainability and Development) is a highly diversified group of companies with a global presence. In the pharmaceutical/biotechnological field, it operates throughout the value chain, contributing its specialized knowledge in scientific research, development, manufacturing, sales and marketing of a wide range of products for human health. Insud Argentina stands out developing monoclonal antibodies, vaccines and immunotherapeutic polyclonal sera.
Nowadays we are developing alternative proteins, together with biotech startups.
Nowadays we are developing alternative proteins, together with biotech startups.